{
"NDC": {
"NDCCode": "42571-477-47",
"PackageDescription": "1 BOTTLE in 1 CARTON (42571-477-47) / 100 mL in 1 BOTTLE",
"NDC11Code": "42571-0477-47",
"ProductNDC": "42571-477",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Valganciclovir",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Valganciclovir",
"DosageFormName": "POWDER, FOR SOLUTION",
"RouteName": "ORAL",
"StartMarketingDate": "20260601",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA218838",
"LabelerName": "Micro Labs Limited",
"SubstanceName": "VALGANCICLOVIR HYDROCHLORIDE",
"StrengthNumber": "50",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-06-02",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260601",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}